Phenomex Inc Quick Ratio (CELL) starting from the second quarter 2023 to second quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Phenomex Inc   (NASDAQ: CELL)

Phenomex Inc 's Quick Ratio

CELL's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the second quarter 2023, Quick Ratio deteriorated to 0.73 a new company low.

Within Laboratory Analytical Instruments industry 23 other companies have achieved higher Quick Ratio than Phenomex Inc in second quarter 2023. While Quick Ratio total ranking in the second quarter 2023 has deteriorated compared to the prior quarter from 1928 to 2822.

Explain Quick Ratio?
How much Cash & cash equivalents CELL´s has?
What are CELL´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CELL Quick Ratio (Jun 30 2023)
Q2		 (Mar 31 2023)
Q1		 (Dec 31 2022)
Q4		 (Sep 30 2022)
Q3		 (Jun 30 2022)
Q2
Y / Y Current Liabilities Change 41.27 % 68.49 % 53.64 % -3.44 % 4.23 %
Y / Y Cash & cash equivalent Change -78.35 % -68.66 % -51.42 % -38.76 % -33.5 %
Quick Ratio MRQ 0.73 1.07 1.9 3.51 4.79
CELL's Total Ranking # 2822 # 1928 # 1316 # 1011 # 745
Seq. Current Liabilities Change -12.45 % 6.02 % 32.32 % 15.02 % 4.42 %
Seq. Cash & cash equivalent Change -40 % -40.36 % -28.28 % -15.65 % -13.15 %



Quick Ratio second quarter 2023 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 24
Healthcare Sector # 890
Overall Market # 2822


Quick Ratio Statistics
High Average Low
9.97 4.86 0.73
(Sep 30 2020)   (Jun 30 2023)




Financial Statements
Phenomex Inc 's Current Liabilities $ 42 Millions Visit CELL's Balance sheet
Phenomex Inc 's Cash & cash equivalent $ 31 Millions Visit CELL's Balance sheet
Source of CELL's Sales Visit CELL's Sales by Geography


Cumulative Phenomex Inc 's Quick Ratio

CELL's Quick Ratio for the trailling 12 Months

CELL Quick Ratio

 (Jun 30 2023)
12 Months		 (Mar 31 2023)
12 Months		 (Dec 31 2022)
12 Months		 (Sep 30 2022)
12 Months		 (Jun 30 2022)
12 Months
Y / Y Current Liabilities TTM Growth 37.66 % 28.96 % 2.69 % -9.52 % -0.74 %
Y / Y Cash & cash equivalent TTM Growth -57.57 % -46.77 % -37.24 % -30.74 % -25.45 %
Quick Ratio TTM 1.7 2.54 3.72 4.95 5.52
Total Ranking TTM # 4009 # 1420 # 3848 # 3283 # 3691
Seq. Current Liabilities TTM Growth 7.81 % 14.17 % 12.96 % -0.99 % 0.99 %
Seq. Cash & cash equivalent TTM Growth -27.89 % -21.96 % -15.1 % -11.18 % -9.55 %

Quick ratio ranking by company, industry and sector >> Back to CELL Financial Strength Comparisons >> Go to Compare CELL Quick Ratio to its Competitors

On the trailing twelve months basis Due to fall in Current Liabilities in the Q2 2023 to $42.23 millions, cumulative Quick Ratio decreased to 1.7 below the Phenomex Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 30 other companies have achieved higher Quick Ratio than Phenomex Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2023 from 1420 to 4009.

Explain Quick Ratio?
How much Cash & cash equivalents CELL´s has?
What are CELL´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Laboratory Analytical Instruments Industry # 31
Healthcare Sector # 1090
Within the Market # 4009


trailing twelve months Quick Ratio Statistics
High Average Low
7.64 5.16 1.71
(Jun 30 2021)   (Jun 30 2023)




Companies with similar Quick Ratio in the quarter ending Jun 30 2023, within Laboratory Analytical Instruments Industry Quick RatioJun 30 2023 MRQ Cash & cash equivalentJun 30 2023 MRQ Current Liabilities
Revvity Inc  1.52 $ 2,070.958  Millions$ 1,366.830  Millions
Scientific Industries Inc   1.45 $ 2.489  Millions$ 1.714  Millions
Prenetics Global Limited  1.16 $ 45.706  Millions$ 39.484  Millions
Agilent Technologies inc   0.91 $ 1,329.000  Millions$ 1,457.000  Millions
Phenomex Inc   0.73 $ 30.964  Millions$ 42.225  Millions
Precipio inc   0.60 $ 2.573  Millions$ 4.324  Millions
Accelerate Diagnostics Inc   0.58 $ 29.282  Millions$ 50.321  Millions
Bruker Corporation  0.55 $ 574.800  Millions$ 1,050.900  Millions
Kewaunee Scientific Corporation  0.49 $ 21.568  Millions$ 44.229  Millions
Thermogenesis Holdings Inc   0.41 $ 4.450  Millions$ 10.986  Millions
Harvard Bioscience Inc   0.19 $ 4.324  Millions$ 22.942  Millions
Avantor Inc   0.15 $ 236.400  Millions$ 1,550.100  Millions

Date modified: 2026-09-08T15:11:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.